A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer

por Bozkaya, Yakup, Özdemir, Nuriye Yıldırım, Yazıcı, Ozan, Demirci, Nebi Serkan, Kurtipek, Alican, Erdem, Gökmen Umut, Ergün, Yakup, Zengin, Nurullah
Publicado 2018

Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?

por Demirci, Nebi Serkan, Çavdar, Eyyüp, Erdem, Gokmen Umut, Hatipoglu, Engin, Celik, Emir, Sezer, Sevilay, Yolcu, Ahmet, Dogan, Mutlu, Seber, Erdogan Selcuk
Publicado 2023

The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study

por Erdal, Gulcin Sahingoz, Polat, Ozlem, Erdem, Gokmen Umut, Korkusuz, Ramazan, Hindilerden, Fehmi, Yilmaz, Mesut, Yasar, Kadriye Kart, Isiksacan, Nilgun, Tural, Deniz
Publicado 2021

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas

por Aydin, Dincer, Kefeli, Umut, Ozcelik, Melike, Erdem, Gokmen Umut, Sendur, Mehmet Ali, Yildirim, Mahmut Emre, Oven, Basak Bala, Bilici, Ahmet, Gumus, Mahmut
Publicado 2023